Department of Pharmacology

Displaying 11 - 14 of 14

Vanderbilt study suggests way to prevent rare lung disease

Vanderbilt study suggests way to prevent rare lung disease

Related Categories: 
American Heart Association biomedical engineering David Merryman Department of Pediatrics Department of Pharmacology NIH NHLBI circulation research

Four researchers receive Young Investigator Grants

Four Vanderbilt University researchers are among 200 recipients of this year’s Young Investigator Grants awarded by the Brain & Behavior Research Foundation to support “innovative ideas for groundbreaking neurobiological research.”

Related Categories: 
NARSAD Psychology and human development samuel centanni vanderbilt center for addiction research Vanderbilt Center for Neuroscience Drug Discovery Basic Sciences brain & behavior research foundation daniel foster Department of Pharmacology erin calipari Department of Molecular Physiology and Biophysics

Scavengers “protect” HDL

High-density lipoprotein (HDL) is widely thought to protect against the development of atherosclerosis, yet drugs that raise levels of HDL cholesterol (HDL-C) have failed to reduce the risk of heart disease.

Related Categories: 
AHA American Heart Association atherosclerosis Basic Sciences cholesterol Department of Pharmacology HDL Journal of Biological Chemistry NHLBI NIH Research Sean Davies

Roden’s circulatory diseases research honored

Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.

Related Categories: 
Dan Roden Award for Research in Circulatory Diseases Basic Sciences cardiovascular disease Department of Biomedical Informatics Department of Medicine Department of Pharmacology John A. Oates Institute for Experimental Therapeutics McGill University personalized medicine